Tratamiento con desmopresina en la enfermedad de Von Willebrand

Sevrini, Inés; Chalkling Bardelli, Ana.
Arch. med. interna (Montevideo) ; 30(4): 107-109, dic. 2008.
Artículo en Español | LILACS | ID: lil-566530

Documentos relacionados

  1. How I treat von Willebrand disorders in older adults.
  2. Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study.
  3. Desmopressin stimulation testing: Response to intravenous and intranasal forms.
  4. Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.
  5. Towards novel treatment options in von Willebrand disease.
  6. Desmopressin (DDAVP) use in patients with von Willebrand disease: A single-centre retrospective review of test response and clinical outcomes.
  7. Letter to the Editor: Experience with subcutaneous desmopressin in patients with von Willebrand disease (VWD) and qualitative platelet function disorders.
  8. von Willebrand factor clearance - biological mechanisms and clinical significance.
  9. How we diagnose 2M von Willebrand disease (VWD): Use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types.
  10. A personalized approach to the management of VWD.